International Neuromodulation Society 13th World Congress May 27 - June 1, 2017
New! Register Now | Registration Fees
Submit an Abstract | Call for Abstracts | Abstract Deadline: January 31, 2017
New! Pre-Conference: Innovations in Neuromodulation | Emerging Company Panel Application
Commercial Supporter and Exhibitor Prospectus
The INS 13th World Congress Takes Place in Edinburgh, Scotland
The International Neuromodulation Society presents the world’s premier scientific congress on the full breadth of neuromodulation therapy. Begun in 1992, the international meeting now attracts more than 1,400 delegates.
The INS is excited to announce the 13th World Congress in Edinburgh, Scotland. Please mark your calendars and make plans to join us May 27 – June 1 2017 at the Edinburgh International Conference Centre.
The INS Executive Officers and congress organizers are delighted to welcome attendees to this scenic and historic capital of Scotland. The impressive meeting venue is in the heart of Edinburgh, a few steps from historic attractions, hotels, and eateries and just 20 minutes from the international airport.
Within walking distance are the iconic medieval fortress and Royal Palace of Holyroodhouse, which overlook neoclassical neighborhoods and parks. In addition to its beauty, the city has a rich history of medical inquiry and discovery. That tradition continues today in internally recognized neuroscience research. Thanks to coordination by the Neuromodulation Society of the United Kingdom and Ireland past president, Mr. Roger Strachan, some highlights of neuroscience research at the University of Edinburgh will be presented at this meeting.
With the title “Neuromodulation: Technology Changing Lives,” the congress emphasizes our field’s transformative force on the treatment of disease states – how it is approached now and will be approached in the not-too-distant future. We see almost daily reports in the mainstream media of innovation in the area of neuromodulation treating not only pain, but also many conditions of the cardiovascular, neurological, gastrointestinal, urological and other systems. This meeting will mark an important time for our field: The emergence of the “digital drug” and the next evolution in healthcare.
The overall 3.5-day scientific program offers multiple tracks by an esteemed international faculty to serve the needs of a multidisciplinary audience of medical specialists and trainees, scientists, engineers, and allied health professionals. Every day will feature sessions on neuromodulation for pain, as well as brain stimulation for neurological and cognitive disorders and neurorehabilitation, as well as specialty sessions such as neuromodulation for systemic disease, heart disease, urologic, gastrointestinal motility and metabolic and disorders. Among the plenary sessions will be a focus on the latest international guidance being published in Neuromodulation: Technology at the Neural Interface in 2017 by the Neuromodulation Appropriateness Consensus Committee and the Polyanalgesic Consensus Conference members.
In addition to having parallel program tracks, the meeting will feature recognition of the five best scientific abstracts during the General Assembly of members on May 30. There will also be a lecture by a pioneer in the field, who is being honored as the fourth INS Giant of Neuromodulation on May 31.
The scientific program is preceded by two preconferences. On May 27, there is a session focusing on less-invasive and non-invasive therapies. On May 28 is the fourth daylong innovation-and-investment preconference entitled “Innovations in Neuromodulation: The Challenge of Reimbursement: Can We Do This Smarter?” Speakers will include representatives from National Institute of Health Research, NICE, and BSI group (a notified body). Year on year this has become very popular and demonstrates the complex interactions and roles that inventors, investors, researchers, clinicians, regulators have in developing safe and effective devices to benefit both patients and the health care system. Emerging companies interested in presenting their companies on the panels are invited to apply by January 22, 2017 to participate during a preconference panel at the Innovations Day.
If you have not already made your travel plans, we encourage you to register and book your hotel reservations now. Note: Citizens of certain countries and territories need a visa to enter the United Kingdom. Visa processing times vary from country to country, so please check the UK Government Website and apply for a visa, if necessary, well in advance of your trip. Also, those traveling from outside of the United Kingdom will need a valid passport to enter.
The INS leadership anticipates a rewarding experience for all attendees. We invite you to submit your abstracts by January 31, 2017 and we look forward to welcoming you in Edinburgh!
Innovations in Neuromodulation Emerging Company Panel application deadline: January 22, 2017
Early registration: January 25, 2017
Your abstract submissions are welcomed by January 31, 2017
Edinburgh Marathon Festival
For our running enthusiasts, the Edinburgh Marathon Festival is taking place immediately preceding our main congress on Sunday, the 28th of May. If you are interested in running the marathon, half marathon, 10K or 5K with "Team INS Edinburgh 2017," to raise neuromodulation awareness, register as an individual on the marathon website by the 7th of January on the marathon website. Once you have entered officially, please notify the INS executive office of your event (email@example.com) and your shirt size for your “Team INS Edinburgh 2017” singlet. Note: Runners will miss out on our excellent pre-conference session, Innovations in Neuromodulation, as the events are happening concurrently.
Previous INS Congresses
Giant of Neuromodulation Awards
Future INS and Chapter events can be found under "Events", also view individual Chapter Pages for information.
Previous Congress Supporters & Exhibitors